Inhaled Anticholinergic Drug Therapy and the Risk of Acute Urinary Retention in Chronic Obstructive Pulmonary Disease | Zendy

Anne L. Stephenson | Zendy; Dallas Seitz | Zendy; Chaim M. Bell | Zendy; Andrea Gruneir | Zendy; Andrea S. Gershon | Zendy; Peter C. Austin | Zendy; Longdi Fu | Zendy; George Anderson | Zendy; Paula A. Rochon | Zendy; Sudeep S. Gill | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Inhaled Anticholinergic Drug Therapy and the Risk of Acute Urinary Retention in Chronic Obstructive Pulmonary Disease

Author(s) -

Anne L. Stephenson,

Dallas Seitz,

Chaim M. Bell,

Andrea Gruneir,

Andrea S. Gershon,

Peter C. Austin,

Longdi Fu,

George Anderson,

Paula A. Rochon,

Sudeep S. Gill

Publication year - 2011

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/archinternmed.2011.170

Subject(s) - medicine , copd , anticholinergic , odds ratio , confidence interval , population , anticholinergic agents , logistic regression , physical therapy , environmental health

Inhaled anticholinergic medications (IACs) are widely used treatments for chronic obstructive pulmonary disease (COPD). The systemic anticholinergic effects of IAC therapy have not been extensively studied. This study sought to determine the risk of acute urinary retention (AUR) in seniors with COPD using IACs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research